Tag: Epilepsy drugs

Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally [1.5.4]. For the 70% of people whose seizures can be controlled, the answer to 'What is the most common medicine for epilepsy?' is crucial for management [1.2.5].

A 2018 study on antiepileptic drug use found regular use of medications with cognitive adverse effects was associated with a 59% increased risk of incident dementia. Understanding which epilepsy drugs cause dementia is crucial for long-term treatment planning, as various factors influence cognitive outcomes.

According to the UK's Medicines and Healthcare products Regulatory Agency (MHRA), antiepileptic drugs are sorted into three categories to provide guidance on the safety of switching between different manufacturers' products. Understanding **what are the Category 3 drugs for epilepsy** is crucial, as this group contains medications where generic substitution is generally considered safe and clinically appropriate. This classification helps inform prescribing practices and minimize the risk of therapeutic failures or adverse effects associated with brand-to-generic changes.